Presentation is loading. Please wait.

Presentation is loading. Please wait.

Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients  Takahiro.

Similar presentations


Presentation on theme: "Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients  Takahiro."— Presentation transcript:

1 Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients  Takahiro Aoki, Katsuyoshi Koh, Yutaka Kawano, Makiko Mori, Yuki Arakawa, Motohiro Kato, Ryoji Hanada  Biology of Blood and Marrow Transplantation  Volume 22, Issue 4, Pages (April 2016) DOI: /j.bbmt Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 Comparison of immunological parameters. (A,B) Lymphocyte counts and IgG values were measured at the time of varicella vaccination and compared with reference to the time interval from HSCT to varicella vaccination. (C,D) CD4 T cell counts and CD4/8 ratios were measured and calculated at the beginning of administering live vaccines; counts and ratios were compared with reference to the time interval from HSCT to the initiation of live vaccines. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients  Takahiro."

Similar presentations


Ads by Google